Journal article
Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response
The journal of neuropsychiatry and clinical neurosciences, Vol.29(2), pp.179-182
2017
DOI: 10.1176/appi.neuropsych.16100181
PMCID: PMC5592731
PMID: 27899052
Abstract
This study provides support for the hypothesis that treatment response to an initial course of repetitive transcranial magnetic stimulation (rTMS) for depression predicts the magnitude of response to a subsequent course of rTMS in the setting of symptom relapse.
Details
- Title: Subtitle
- Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response
- Creators
- Michael S Kelly - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Albino J Oliveira-Maia - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Margo Bernstein - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Adam P Stern - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Daniel Z Press - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Alvaro Pascual-Leone - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)Aaron D Boes - From the Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston (MSK, AJO-M, MB, APS, DZP, AP-L, ADB); the University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, N.Y. (MSK); the Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisboa, Portugal (AJO-M); the Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal (AJO-M); NOVA Medical School|Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal (AJO-M); the Department of Psychiatry at BIDMC (APS); and the Noninvasive Brain Stimulation Clinical Program, Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa (ADB)
- Resource Type
- Journal article
- Publication Details
- The journal of neuropsychiatry and clinical neurosciences, Vol.29(2), pp.179-182
- Publisher
- United States
- DOI
- 10.1176/appi.neuropsych.16100181
- PMID
- 27899052
- PMCID
- PMC5592731
- ISSN
- 0895-0172
- eISSN
- 1545-7222
- Grant note
- R25 NS065743 / NINDS NIH HHS UL1 TR001102 / NCATS NIH HHS K12 NS098482 / NINDS NIH HHS K12 HD027748 / NICHD NIH HHS R21 MH099196 / NIMH NIH HHS
- Language
- English
- Date published
- 2017
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Neurology; Psychiatry; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Pharmacy Practice and Science; Neurology (Pediatrics)
- Record Identifier
- 9984013916202771
Metrics
17 Record Views